X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Torrent Pharma with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs SUVEN LIFE - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA SUVEN LIFE TORRENT PHARMA/
SUVEN LIFE
 
P/E (TTM) x 34.0 14.0 242.4% View Chart
P/BV x 5.1 3.3 153.9% View Chart
Dividend Yield % 1.1 0.5 202.0%  

Financials

 TORRENT PHARMA   SUVEN LIFE
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-17
SUVEN LIFE
Mar-17
TORRENT PHARMA/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs1,768229 773.7%   
Low Rs1,186151 784.6%   
Sales per share (Unadj.) Rs346.142.7 810.5%  
Earnings per share (Unadj.) Rs55.26.9 805.4%  
Cash flow per share (Unadj.) Rs73.38.5 859.2%  
Dividends per share (Unadj.) Rs14.001.00 1,400.0%  
Dividend yield (eoy) %0.90.5 179.9%  
Book value per share (Unadj.) Rs257.152.4 490.6%  
Shares outstanding (eoy) m169.22127.28 133.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.34.4 96.0%   
Avg P/E ratio x26.827.7 96.6%  
P/CF ratio (eoy) x20.122.2 90.6%  
Price / Book Value ratio x5.73.6 158.6%  
Dividend payout %25.414.6 173.8%   
Avg Mkt Cap Rs m249,88724,158 1,034.4%   
No. of employees `00011.81.0 1,159.5%   
Total wages/salary Rs m9,934522 1,904.2%   
Avg. sales/employee Rs Th4,971.55,349.7 92.9%   
Avg. wages/employee Rs Th843.2513.5 164.2%   
Avg. net profit/employee Rs Th792.4858.1 92.3%   
INCOME DATA
Net Sales Rs m58,5695,435 1,077.6%  
Other income Rs m2,233211 1,058.6%   
Total revenues Rs m60,8025,646 1,076.9%   
Gross profit Rs m13,7731,291 1,067.1%  
Depreciation Rs m3,069214 1,433.5%   
Interest Rs m2,05657 3,619.0%   
Profit before tax Rs m10,8811,231 884.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,545359 430.6%   
Profit after tax Rs m9,336872 1,070.8%  
Gross profit margin %23.523.7 99.0%  
Effective tax rate %14.229.2 48.7%   
Net profit margin %15.916.0 99.4%  
BALANCE SHEET DATA
Current assets Rs m53,8414,917 1,095.0%   
Current liabilities Rs m31,6121,186 2,665.3%   
Net working cap to sales %38.068.6 55.3%  
Current ratio x1.74.1 41.1%  
Inventory Days Days9762 156.4%  
Debtors Days Days8431 272.2%  
Net fixed assets Rs m42,0793,154 1,334.0%   
Share capital Rs m846127 664.7%   
"Free" reserves Rs m42,6556,543 651.9%   
Net worth Rs m43,5016,670 652.2%   
Long term debt Rs m22,408259 8,641.8%   
Total assets Rs m101,2508,157 1,241.2%  
Interest coverage x6.322.7 27.8%   
Debt to equity ratio x0.50 1,325.0%  
Sales to assets ratio x0.60.7 86.8%   
Return on assets %11.311.4 98.8%  
Return on equity %21.513.1 164.2%  
Return on capital %19.618.6 105.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m20,0664,996 401.6%   
Fx outflow Rs m5,304959 553.1%   
Net fx Rs m14,7624,037 365.7%   
CASH FLOW
From Operations Rs m10,1271,088 930.5%  
From Investments Rs m-7,869-3,107 253.3%  
From Financial Activity Rs m-1,918-300 638.9%  
Net Cashflow Rs m212-2,319 -9.1%  

Share Holding

Indian Promoters % 71.5 63.4 112.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.0 0.0 -  
FIIs % 12.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 8.8 36.5 24.1%  
Shareholders   26,511 37,287 71.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   CIPLA  NOVARTIS  DR. DATSONS LABS  MERCK LTD  SANOFI INDIA  

Compare TORRENT PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Weakening Rupee; Key Earnings Report; IDBI Bank, ONGC among Top Stocks in Action Today(Pre-Open)

Indian share markets rose on Friday after rupee recovered from its a 16-month low against the dollar. The S&P BSE Sensex ended at 34,925, up 262 points.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


May 25, 2018 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS